Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2013
HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantationAmer M Zeidan, Patrick M Forde, Heather Symons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort StudySuman Paul, Marianna Zahurak, Leo Luznik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 8, 2024
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia AEmily Symington, Savita Rangarajan, Will Lester, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 19, 2007
DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivoMichael A Chattergoon, Karuppiah Muthumani, Yutaka Tamura, et al.
Blood|June 3, 2004
Association of Foxp3 regulatory gene expression with graft-versus-host diseaseYuji Miura, Christopher J Thoburn, Emilie C Bright, et al.
Journal of Thrombosis and Haemostasis : JTH|January 12, 2025
Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 studyMargareth C Ozelo, Jane Mason, Amy L Dunn, et al.
Pageof 15